InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.54
(
-0.27%
)
Bitcoin
56,448.30
(
-3.18%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: BTH post# 23185

Monday, 10/22/2012 9:39:33 AM

Monday, October 22, 2012 9:39:33 AM

Post# of 80490
The upgrade is nice and the downgrade sucks.
The company probably did go conservative on the sales projection but I think the analysts are a bit lame.

I thought the update on 113 was the most significant part of the presentation.
The fact that they have the dose up to 300mg without any significant safety issues and the drug appears to work well on brain mets was much more significant than the pona first year sales number, IMHO.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up